Specialty Pharmacy

Radon already associated with lung cancer development.

Combination imaging found to reduce recall rate in patients with breast cancer.

Top news of the day from across the health care landscape.

Informed choices of therapy regimens could save up to $1 billion annually in cancer drug spending.

Selinexor combined with liposomal doxorubicin and dexamethasone shows promise.

Study hopes to overcome significant challenges in producing an HIV vaccine.

Top news of the day from across the health care landscape.

Metformin found to improve survival in breast cancer and shows promise in endometrial hyperplasia.

Progression-free survival was seen in 16 patients treated with a combination of nivolumab and ipilimumab.

Study of clinical development success rates finds phase 2 trials are less successful than any other R&D phase.

Cost and access burdens among individuals at-risk for cancer improved through phone counseling.

Patients with mutations in the gene NR1H3 have a 70% chance of developing a progressive form of MS.

Nerve axons and muscle fibers lose contact early in amyotrophic lateral sclerosis.

Study finds exercise may improve chronic inflammation and cognitive impairment in the treatment of cancer patients.

Top news of the day from across the health care landscape.

ASCO is conducting a clinical trial to evaluate how different targeted cancer drugs work to find additional uses outside its FDA indication.

Generic drug pricing and medical marijuana access among pharmacy-related legislation at the state level.

Daclizumab (Zinbryta) treats adults with relapsing forms of multiple sclerosis.

Zinbryta is a long-acting injection that is self-administered by the patient every month.

Pharmacist was the only job on the list directly related to health care.

Patients with lung cancer who reported symptoms via Moovcare showed 1-year survival of 75%.

The highest retail prices for 23 different cancer drugs was found in the United States.

Specialty pharmacy stakeholders need to focus on measureable near-term processes that could improve speed to therapy.

Adding temozolomide (Temodar) to chemoradiation reduced the risk of death by 33% in elderly glioblastoma patients.

Increased unemployment shows a negative impact on worldwide cancer mortality.

Aggressive treatment approach shows promise in children with high risk brain cancer.

Choosing Wisely recommendations have not substantially changed the care received by patients in the last 30 days of life.

Top news of the day from across the health care landscape.